U01-CA86402/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	1
2005	1
2006	3
2007	2
2008	4
2009	2
2010	3
2011	4
2012	5
2013	1
2014	3
2015	2
2018	1
2019	1
2024	0

1

The dilemma of prostate-specific antigen testing.

Leach R, Thompson IM. Leach R, et al. Arch Intern Med. 2012 Jun 11;172(11):835-6. doi: 10.1001/archinternmed.2012.1226. Arch Intern Med. 2012. PMID: 22905350 Free PMC article. No abstract available.

2

Biomarkers for prostate cancer detection.

Parekh DJ, Ankerst DP, Troyer D, Srivastava S, Thompson IM. Parekh DJ, et al. J Urol. 2007 Dec;178(6):2252-9. doi: 10.1016/j.juro.2007.08.055. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936845 Review.

3

Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.

Hernández J, Thompson IM. Hernández J, et al. Cancer. 2004 Sep 1;101(5):894-904. doi: 10.1002/cncr.20480. Cancer. 2004. PMID: 15329895 Free article. Review.

4

Prevention of prostate cancer: outcomes of clinical trials and future opportunities.

Thompson I Jr, Kristal A, Platz EA. Thompson I Jr, et al. Am Soc Clin Oncol Educ Book. 2014:e76-80. doi: 10.14694/EdBook_AM.2014.34.e76. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857150 Free PMC article. Review.

5

What do the screening trials really tell us and where do we go from here?

Etzioni RD, Thompson IM. Etzioni RD, et al. Urol Clin North Am. 2014 May;41(2):223-8. doi: 10.1016/j.ucl.2014.01.002. Epub 2014 Feb 19. Urol Clin North Am. 2014. PMID: 24725484 Free PMC article. Review.

6

The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.

Feng Z, Kagan J, Pepe M, Thornquist M, Ann Rinaudo J, Dahlgren J, Krueger K, Zheng Y, Patriotis C, Huang Y, Sorbara L, Thompson I, Srivastava S. Feng Z, et al. Clin Chem. 2013 Jan;59(1):68-74. doi: 10.1373/clinchem.2012.185140. Epub 2012 Nov 27. Clin Chem. 2013. PMID: 23193062 Free PMC article. Review.

7

Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening.

Gelfond J, Choate K, Ankerst DP, Hernandez J, Leach RJ, Thompson IM Jr. Gelfond J, et al. J Urol. 2015 Jul;194(1):46-51. doi: 10.1016/j.juro.2015.02.043. Epub 2015 Feb 14. J Urol. 2015. PMID: 25686543

8

Prostate cancer detection: a view of the future.

Thompson IM Jr, Leach RJ, Ankerst DP. Thompson IM Jr, et al. Eur Urol. 2011 Feb;59(2):191-3. doi: 10.1016/j.eururo.2010.11.019. Epub 2010 Dec 3. Eur Urol. 2011. PMID: 21130561 Free PMC article. No abstract available.

9

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM. Baillargeon J, et al. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5. doi: 10.1158/1055-9965.EPI-06-0082. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835332

10

Total prostate specific antigen stability confirmed after long-term storage of serum at -80C.

Reed AB, Ankerst DP, Leach RJ, Vipraio G, Thompson IM, Parekh DJ. Reed AB, et al. J Urol. 2008 Aug;180(2):534-7; discussion 537-8. doi: 10.1016/j.juro.2008.04.021. Epub 2008 Jun 11. J Urol. 2008. PMID: 18550121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year